Topics:
Primary Pulmonary Hypertension
Current versions available to download
Current translated versions available to download:
Authors
Nazzareno Galié (Chairperson), Adam Torbicki (Poland), Robyn Barst (USA), Philippe Dartevelle (France), Sheila Haworth (UK), Tim Higenbottam (UK), Horst Olschewski (Germany), Andrew Peacock (UK), Giuseppe Pietra (Switzerland), Lewis J. Rubin (USA), Gerald Simonneau (Co-Chairperson) (France)
|
Table of contents: Full Text (ESC Clinical Practice Guidelines)
|
|
|
Clinical classification of pulmonary hypertension
|
- Idiopathic pulmonary arterial hypertension
- Risk factors and associated conditions
- Pulmonary veno-occlusive disease and pulmonary capillary hemangiomatosis
- Classification of congenital systemicto-pulmonary shunts
|
Pathology of pulmonary arterial hypertension
|
- Pulmonary arteriopathy
- Pulmonary occlusive venopathy
- Pulmonary microvasculopathy
|
Pathogenesis of pulmonary arterial hypertension
|
Diagnostic strategy
|
- Clinical suspicion of pulmonary hypertension
- Detection of pulmonary hypertension
- ECG
- Chest radiograph
- Transthoracic Doppler-echocardiography (TTE)
|
Pulmonary hypertension clinical class identification
|
- Pulmonary function tests and arterial blood gases
- Ventilation and perfusion (V/Q) lung scan
- High resolution CT of the lung
- Contrast enhanced spiral CT of the lung, pulmonary angiography and magnetic resonance imaging
|
Pulmonary arterial hypertension evaluation (type, exercise capacity, hemodynamics)
|
- Blood tests and immunology
- Abdominal ultrasound scan
- Exercise capacity
- Hemodynamics
- Lung biopsy
|
Assessment of severity
|
- Clinical variables
- Exercise capacity
- Echocardiographic parameters
- Hemodynamics
- Blood tests
|
Treatment
Introduction to level of evidence and grade of recommendation
|
General measures
|
- Physical activity
- Travel/altitude
- Prevention of infections
- Pregnancy, birth control and post-menopausal hormonal therapy
- Haemoglobin levels
- Concomitant medications
- Psychological assistance
- Elective surgery
|
Pharmacological treatment
|
- Oral anticoagulant treatment
- Diuretics
- Oxygen
- Digitalis and dobutamine
- Calcium-channel blockers
|
Synthetic prostacyclin and prostacyclin analogues
|
- Enpoprostenol
- Treprostinil
- Sodium beraprost
- Iloprost
- Intravenous Iloprost
|
Endothelin-1 receptor antagonists
|
- Bosentan
- Sitaxsentan
- Ambrisentan
|
Type 5 phosphodiesterase inhibitors: Sildenafil
|
Combination therapy
|
Interventional procedures: Balloon atrial septostomy, Lung transplantation
|
Treatment algorithm
|
Previous versions
A complete list of ESC Clinical Practice Guidelines (current and previous versions) endorsed by ESC National Society Members is available
here